How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Coinbase co-founder and CEO Brian Armstrong joins Yahoo Finance Executive Editor Brian Sozzi to explain how they're building ...
The Escalating Demand for a Business Insolvency Risk Assessment Given the current economic landscape in the UK—characterized by persistent inflation and post-Brexit market shifts—corporate failure ...
Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
Shanku Niyogi of Databricks walks through the architecture behind Lakebase, LTAP and Lakehouse//RT – and renames an industry ...
As inference workloads evolve from discrete question-and-answer exchanges into persistent, multi-step agentic systems, GPU ...
Read how Microsoft Security has advanced its agentic vulnerability detection system, codename MDASH, integrating into ...
Remember the last time Anthropic tussled with the Trump administration, all the way back in February, when a coterie of competing AI researchers and CEOs (even Sam Altman!) quickly came to Anthropic’s ...